New supplement – Bimuno – helps IBS sufferers
Bimuno is a ‘second generation’ galactooligosaccharide with prebiotic properties, which means it is not destroyed, digested or absorbed in the stomach or small intestine. It therefore reaches the colon intact to selectively target and feed the body's immunity boosting bifidobacteria while reducing harmful bacteria.
As a result, a recent study by the Imperial College Healthcare NHS Trust, Central Middlesex Hospital and the University of Reading, published in the Alimentary Pharmacology & Therapeutics found that those IBS patients taking Bimuno had significantly less bloating and abdominal pain, with some also reporting reduced anxiety scores and better quality of life.
The research also examined Bimuno's effect on the gut flora of IBS patients aged between 18 and 80, finding that it was able to stimulate bifidobacteria – natural ‘good’ bacteria and reduce the level of some harmful bacteria, including strains of Clostridium and Bacteroides.
The 12-week trial involved 44 patients who met the Rome II criteria for the diagnosis of IBS. Professor Nick Read, medical director of the Gut Trust commented: 'We are very encouraged to see the positive results of this trial, and welcome any new scientifically proven methods for treating IBS.’
Click here for more research on the management IBS
Top of page
If you found this article interesting, you will find many more general articles and research reports on coeliac disease here, and lots of information on the management of coeliac disease here.
You can also find articles and research reports on gluten intolerance here and articles on a wide range of other digestive conditions here.
For hundreds of gluten free foods see our freefrom food section here, and for nearly 800 gluten-free recipes see here.
And if you would like to get our FREE fortnightly e-newsletter with new products, recipes, articles and all the latest news from the allergy and freefrom world, just sign up here.